Japan’s Nikkei Cruises to 34-year Peak, Briefly Breaching 38,000 Range (Update 1)
13:06 JST, February 13, 2024 (updated at 16:30 JST)
TOKYO, Feb 13 (Reuters) – Japan’s Nikkei share average closed at a fresh 34-year high on Tuesday as trading resumed after a long holiday weekend, with tech-related shares and strong corporate earnings supporting the benchmark stock index.
The Nikkei climbed 2.89% to 37,963.97 to its highest since January 1990, after brieflybreaching 38,000 points.
The broader Topix rose 2.12%.
Chip-sector giant Tokyo Electron Ltd gained 13.33%, making it the best performer of the day.
SoftBank Group Corp rose 6.27%, buoyed by the rally in semiconductor developer ARM HoldingsARM.O shares, in which SoftBank has a 90% stake.
Among other top gainers, Tokio Marine Holdings Incand MS&AD Insurance Group Holdings Inc gained 11% and 10.82%, respectively.
Japanese equities also received a boost from a strong performance on Wall Street and a weakened yen, boosting the value of overseas revenue for exporters.
The yen traded around 149.47 per dollar JPY= during the session.
“We have raised our outlook for Japanese equities in 2024 (from 2,500 to 2,650 for TOPIX, from 35,000 to 37,000 for the Nikkei 225), taking into account changes in macroeconomic conditions, including the yen weakening early in the year, and progress on structural reforms,” wrote J.P. Morgan analysts in a note earlier this month.
Out of the index’s 225 constituents, 196 gained, while 26 declined.
As the Nikkei climbs toward its all-time high, the U.S. consumer price index (CPI) report out later on Tuesday will be in focus.
“Nikkei moves have been more closely tied to the yen recently, suggesting that any yen strength on the back of U.S. CPI release today, or signs of verbal intervention, could tactically disrupt the rally in Nikkei,” said Charu Chanana, head of currency strategy at Saxo Markets.
Otsuka Holdings was among the decliners, shedding 5.05% after the company said its experimental drug failed to meet a primary late-stage trial goal in treating agitation associated with dementia due to Alzheimer’s disease.
"News Services" POPULAR ARTICLE
-
EU Ratchets up Pressure on TikTok’s New Rewards App over Risks to Kids, Warns of Suspension
-
Japan’s Nikkei Ends 1% Higher after Sharp Fall; Chip-Related Shares Weigh (Update 1)
-
Japan’s Yen Hits 155 Per Dollar, Weakest Since 1990
-
Japan’s Nikkei Stumbles as Yen Gains, Mixed US Peers (Update 1)
-
Strong Solar Storm Hits Earth, Could Disrupt Communications and Produce Northern Lights in US
JN ACCESS RANKING
- Weakening Yen Adds Complexity to BOJ’s Rate Hike Decisions; Rising Commodity Prices may Impact ‘Virtuous Cycle’ Efforts
- Japanese Seafood Exports to China Sink 57% in FY23; U.S. Becomes Largest Seafood Export Destination
- 70% of Japan Companies to Raise Pay Scales in FY 2024
- 48.6% of Global Patent Applications Related to All-Solid-State Batteries Came from Japanese Firms; Panasonic Tops List
- Core Consumer Prices Rise 2.8% in Fiscal 2023